Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4429)
All Articles published online
|
Jan 7, 2012 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, Al Qurashi SH, Al Ghamdi GA, Al Hejaili FF, Al Balwi MA, Al Sayyari AA. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 2012; 18(1): 55-63 [PMID: 22228971 DOI: 10.3748/wjg.v18.i1.55] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i1/55.htm |
| Number | Citing Articles |
| 1 |
Qussai Hassan, Bruno Roche, Camille Buffet, Thomas Bessede, Didier Samuel, Bernard Charpentier, Antoine Durrbach. Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha. Transplant International 2012; 25(9): 941 doi: 10.1111/j.1432-2277.2012.01520.x
|
| 2 |
AbdullahS Alghamdi, FaisalM Sanai, Mona Ismail, Hamdan Alghamdi, Khalid Alswat, Adel Alqutub, Ibrahim Altraif, Hemant Shah, FalehZ Alfaleh. SASLT practice guidelines: Management of hepatitis C virus infection. Saudi Journal of Gastroenterology 2012; 18(7): 1 doi: 10.4103/1319-3767.101155
|
| 3 |
Faisal M. Sanai, Dujana Mousa, Abdallah Al-Mdani, Ghada Al-Shoail, Hamad Al-Ashgar, Khalid Al Meshari, Ahmed Al-Qahtani, Mayssa Saadeh, Khalid I. Bzeizi, Hassan Aleid. Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C. Journal of Hepatology 2013; 58(6): 1096 doi: 10.1016/j.jhep.2013.02.004
|
| 4 |
Sara Belga, Karen Elizabeth Doucette. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon. World Journal of Gastroenterology 2016; 22(4): 1650-1663 doi: 10.3748/wjg.v22.i4.1650
|
| 5 |
Current World Literature. Current Opinion in Organ Transplantation 2012; 17(6): 688 doi: 10.1097/MOT.0b013e32835af316
|
| 6 |
Fang Wei, Junying Liu, Fen Liu, Huaidong Hu, Hong Ren, Peng Hu, Wenzhe Ho. Interferon-Based Anti-Viral Therapy for Hepatitis C Virus Infection after Renal Transplantation: An Updated Meta-Analysis. PLoS ONE 2014; 9(4): e90611 doi: 10.1371/journal.pone.0090611
|
| 7 |
Marco Carbone, David Mutimer, James Neuberger. Hepatitis C Virus and Nonliver Solid Organ Transplantation. Transplantation 2013; 95(6): 779 doi: 10.1097/TP.0b013e318273fec4
|
| 8 |
Roberto J Carvalho-Filho, Ana Cristina CA Feldner, Antonio Eduardo B Silva, Maria Lucia G Ferraz. Management of hepatitis C in patients with chronic kidney disease. World Journal of Gastroenterology 2015; 21(2): 408-422 doi: 10.3748/wjg.v21.i2.408
|
| 9 |
Cyrielle Delabaudière, Laurence Lavayssière, Gaëlle Dörr, Fabrice Muscari, Marie Danjoux, Federico Sallusto, Jean Marie Peron, Christophe Bureau, Lionel Rostaing, Jacques Izopet, Nassim Kamar. Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation. Transplant International 2015; 28(2): 255 doi: 10.1111/tri.12428
|
| 10 |
Chalermrat Bunchorntavakul, Monthira Maneerattanaporn, Disaya Chavalitdhamrong. Management of patients with hepatitis C infection and renal disease. World Journal of Hepatology 2015; 7(2): 213-225 doi: 10.4254/wjh.v7.i2.213
|
| 11 |
Siu-ka Mak, Ho-kwan Sin, Kin-yee Lo, Man-wai Lo, Shuk-fan Chan, Kwok-chi Lo, Yuk-yi Wong, Lo-yi Ho, Ping-nam Wong, Andrew K. M. Wong. Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up. Clinical and Experimental Nephrology 2017; 21(5): 764 doi: 10.1007/s10157-016-1364-7
|
| 12 |
D. B. Korman, L. A. Ostrovskaya, V. A. Kuz’min. Induction of Oxidative Stress in Tumor Cells: A New Strategy for Drug Therapy of Malignant Tumors. Biophysics 2019; 64(3): 431 doi: 10.1134/S0006350919030102
|
| 13 |
Aamir Bashir, Ashish Verma, Ajay Duseja, Arka De, Pramil Tiwari. Adjuvant Use of Ribavirin With Treatment of Hepatitis C Virus in Kidney Transplant Recipients. Indian Journal of Transplantation 2022; 16(3): 243 doi: 10.4103/ijot.ijot_10_22
|
| 14 |
Yuvaram N. V. Reddy, David Nunes, Vipul Chitalia, Craig E. Gordon, Jean M. Francis. Hepatitis C virus infection in kidney transplantation‐changing paradigms with novel agents. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12659
|
| 15 |
Anais Vallet-Pichard, Stanislas Pol. Hepatitis C virus infection in hemodialysis patients. Clinics and Research in Hepatology and Gastroenterology 2013; 37(4): 340 doi: 10.1016/j.clinre.2013.03.005
|
| 16 |
S. Baid-Agrawal, M. Pascual, D. Moradpour, R. Somasundaram, M. Muche. Hepatitis C Virus Infection and Kidney Transplantation in 2014: What’s New?. American Journal of Transplantation 2014; 14(10): 2206 doi: 10.1111/ajt.12835
|
| 17 |
Susan M. Lerner. Hepatitis C and Renal Transplantation. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 2012; 79(3): 342 doi: 10.1002/msj.21318
|
| 18 |
Jose M. Morales, Fabrizio Fabrizi. Hepatitis C and its impact on renal transplantation. Nature Reviews Nephrology 2015; 11(3): 172 doi: 10.1038/nrneph.2015.5
|
| 19 |
Jonathan Grinstein, Laura M. Lourenco, Helen S. Te, John F. Renz, Valluvan Jeevanandam, Nir Uriel. Accepting Hearts From Hepatitis C–Positive Donor: Can We Expand the Donor Pool?. Journal of Cardiac Failure 2017; 23(10): 762 doi: 10.1016/j.cardfail.2017.05.018
|
| 20 |
Calvin K. W. Tong, Kiran K. Khush. New Approaches to Donor Selection and Preparation in Heart Transplantation. Current Treatment Options in Cardiovascular Medicine 2021; 23(5) doi: 10.1007/s11936-021-00906-5
|
| 21 |
Fabrizio Fabrizi, Alessandra Penatti, Piergiorgio Messa, Paul Martin. Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies. Journal of Medical Virology 2014; 86(6): 933 doi: 10.1002/jmv.23919
|